Adverse event profile of tramadol in recent clinical studies of chronic osteoarthritis pain

References

• Sarzi-Puttini P, Cimmino MA, Scarpa R, et al. Osteoarthritis: an overview of the disease and its treatment strategies. Semin Arthritis Rheum 2005;35:1-10
   PubMed Web of Science ®Google Scholar
• Moore RA, Phillips CJ. Cost of NSAIDs adverse effects to the NHS. J Med Econ 1999;2:45-55
   Google Scholar
• Altman RA, Hochberg MC, Moskowitz RW, et al. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905-15
   PubMed Web of Science ®Google Scholar
• Lee WM. Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 2004;40:6-9
   Google Scholar
• Mazer M, Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J Med Toxicol 2008;4:2-6
   PubMedGoogle Scholar
• Williams HJ, Ward JR, Egger MJ, et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993;36:1196-206
   PubMed Web of Science ®Google Scholar
• Lapane KL, Spooner JJ, Pettitt D. The effect of nonsteroidal anti-inflammatory drugs on the use of gastroprotective medication in people with arthritis. Am J Manag Care 2001;7:402-8
   PubMed Web of Science ®Google Scholar
• Delcò F, Michetti P, Beglinger C, et al. Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. A population-based study in Switzerland. Digestion 2004;69:10-9
   PubMed Web of Science ®Google Scholar
• McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006;296:1633-44
   PubMed Web of Science ®Google Scholar
• Gislason GH, Rasmussen JN, Abildstrom SZ, et al. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med 2009;169:141-9
   PubMed Web of Science ®Google Scholar
• Fosbøl EL, Gislason GH, Jacobsen S, et al. Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study. Clin Pharmacol Ther 2009;85:190-7
   PubMed Web of Science ®Google Scholar
• Scott PA, Kingsley GH, Scott DL. Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials. Eur J Heart Fail 2008;10:1102-7
   PubMed Web of Science ®Google Scholar
• Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs 2003;63:17-32
   PubMed Web of Science ®Google Scholar
• ULTRAM® (tramadol hydrochloride tablets) prescribing information. Raritan, NJ: Ortho–McNeil Pharmaceutical, Inc., 2007
   Google Scholar
• Cicero TJ, Inciardi JA, Adams EH, et al. Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994–2004. Pharmacoepidemiol Drug Saf 2005;14:851-9
   PubMed Web of Science ®Google Scholar
• Adams EH, Breiner S, Cicero TJ, et al. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage 2006;31:465-76
   PubMed Web of Science ®Google Scholar
• Gardner JS, Blough D, Drinkard CR, et al. Tramadol and seizures: a surveillance study in a managed care population. Pharmacotherapy 2000;20:1423-31
   PubMed Web of Science ®Google Scholar
• Mattia C, Coluzzi F. Once-daily tramadol in rheumatological pain. Expert Opin Pharmacother 2006;7:1811-23
   PubMed Web of Science ®Google Scholar
• ULTRAM ER (tramadol HCl) extended-release tablets. An oral once-daily formulation of tramadol. Formulary 2006;41(Suppl.):1-17
   Google Scholar
• Coluzzi F, Mattia C. Chronic non-cancer pain: Focus on once-daily tramadol formulations. Ther Clin Risk Manag 2007;3:819-29
   PubMedGoogle Scholar
• Tiwari SB, Murthy TK, Pai MR, et al. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS Pharm Sci Tech 2003;4:E31
   PubMedGoogle Scholar
• Ispas-Szabo P, Ravenelle F, Hassan I, et al. Structure-properties relationship in cross-linked high-amylose starch for use in controlled drug release. Carbohydr Rs 2000;323:163-75
   PubMed Web of Science ®Google Scholar
• Hair PI, Curran MP, Keam SJ. Tramadol extended-release tablets. Drugs 2006;66:2017-30
   PubMed Web of Science ®Google Scholar
• Fleischmann RM, Caldwell JR, Roth SH, et al. Tramadol for the treatment of joint pain associated with osteoarthritis: a randomized, double-blind, placebo-controlled trial. Curr Ther Res 2001;62:113-28
   Web of Science ®Google Scholar
• Roth SH. Efficacy and safety of tramadol HCl in breakthrough musculoskeletal pain attributed to osteoarthritis. J Rheumatol 1998;25:1358-63
   PubMed Web of Science ®Google Scholar
• Petrone D, Kamin M, Olson W. Slowing the titration rate of tramadol HCl reduces the incidence of discontinuation due to nausea and/or vomiting: a double-blind randomized trial. J Clin Pharm Ther 1999;24:115-23
   PubMed Web of Science ®Google Scholar
• Adler L, McDonald C, O’Brien C, et al. A comparison of once-daily tramadol with normal release tramadol in the treatment of pain in osteoarthritis. J Rheumatol 2002;29:2196-9
   PubMed Web of Science ®Google Scholar
• Bodalia B, McDonald CJ, Smith KJ, et al. A comparison of the pharmacokinetics, clinical efficacy, and tolerability of once-daily tramadol tablets with normal release tramadol capsules. J Pain Symptom Manage 2003;25:142-9
   PubMed Web of Science ®Google Scholar
• Beaulieu AD, Peloso PM, Haraoui B, et al. Once-daily, controlled-release tramadol and sustained-release diclofenac relieve chronic pain due to osteoarthritis: a randomized controlled trial. Pain Res Manag 2008;13:103-10
   PubMed Web of Science ®Google Scholar
• Thorne C, Beaulieu AD, Callaghan DJ, et al. A randomized, double-blind, crossover comparison of the efficacy and safety of oral controlled-release tramadol and placebo in patients with painful osteoarthritis. Pain Res Manag 2008;13:93-102
   PubMed Web of Science ®Google Scholar
• Malonne H, Coffiner M, Sonet B, et al. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 2004;26:1774-82
   PubMed Web of Science ®Google Scholar
• Malonne H, Coffiner M, Fontaine D, et al. Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain. J Clin Pharm Ther 2005;30:113-20
   PubMed Web of Science ®Google Scholar
• Mongin G, Yakusevich V, Köpe A, et al. Efficacy and safety assessment of a novel once-daily tablet formulation of tramadol: a randomised, controlled study versus twice-daily tramadol in patients with osteoarthritis of the knee. Clin Drug Investig 2004;24:545-58
   PubMed Web of Science ®Google Scholar
• Burch F, Fishman R, Messina N, et al. A comparison of the analgesic efficacy of Tramadol Contramid OAD versus placebo in patients with pain due to osteoarthritis. J Pain Symptom Manage 2007;34:328-38
   PubMed Web of Science ®Google Scholar
• Fishman RL, Kistler CJ, Ellerbusch MT, et al. Efficacy and safety of 12 weeks of osteoarthritic pain therapy with once-daily tramadol (Tramadol Contramid OAD). J Opioid Manag 2007;3:273-80
   PubMedGoogle Scholar
• Babul N, Noveck R, Chipman H, et al. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symptom Manage 2004;28:59-71
   PubMed Web of Science ®Google Scholar
• Gana TJ, Pascual MLG, Fleming RRB, et al. Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Curr Med Res Opin 2006;22:1391-401
   PubMed Web of Science ®Google Scholar
• Pascual MLG, Fleming RRB, Gana TJ, et al. Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain. Curr Med Res Opin 2007;23:2531-42
   PubMed Web of Science ®Google Scholar
• Murthy BP, Skee DM, Danyluk AP, et al. Pharmacokinetic model and simulations of dose conversion from immediate- to extended-release tramadol. Curr Med Res Opin 2007;23:275-84
   PubMed Web of Science ®Google Scholar
• Malonne H, Sonet B, Streel B, et al. Pharmacokinetic evaluation of a new oral sustained release dosage form of tramadol. Br J Clin Pharmacol 2004;57:270-8
   PubMed Web of Science ®Google Scholar
• Hernandez-Lopez C, Martinez-Farnos L, Karhu D, et al. Comparative bioavailability between two tramadol once-daily oral formulations. Methods Find Exp Clin Pharmacol 2006;28:373-8
   PubMed Web of Science ®Google Scholar
• Vorsanger G, Xiang J, Jordan D, et al. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients. Clin Ther 2007;29(Suppl.):2520-35
   PubMed Web of Science ®Google Scholar
• ULTRAM® ER (tramadol HCl) Extended-Release Tablets prescribing information. Raritan, NJ: Ortho–McNeil Pharmaceutical, Inc., 2007
   Google Scholar
• Zytram XL® (tramadol HCl controlled-release tablets) prescribing information. Pickering, ON: Purdue Pharma, 2008
   Google Scholar
• Ryzolt™ (tramadol HCl extended-release tablets) prescribing information. Stamford, CT: Purdue Pharma L.P., 2009
   Google Scholar
• Duhmke RM, Cornblath DD, Hollingshead JR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2004:CD003726
   Google Scholar
• Katz N. Methodological issues in clinical trials of opioids for chronic pain. Neurology 2005;65:S32-49
   PubMed Web of Science ®Google Scholar
• Chou R, Clark E, Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J Pain Symptom Manage 2003;26:1026-48
   PubMed Web of Science ®Google Scholar